InnoCare Releases 2022 Third Quarter Results: Star Board Listing for Long-term Growth and Rapid Increase of Orelabrutinib Sales
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2022...

Command Discipline Takes Precedence as Home Ministry Suspends Delhi ACP Manasvi Vashishta
Karnataka High Court Quashes BJP Slogan FIR, Ads Case, Sets 24-Hour Custody Rule
Tamil Nadu Government Allows Six Daily Film Shows Starting at 6 AM
Ranji Trophy: How Nagwaswalla, Gaja, and Patel Put Gujarat in Control Against Kerala
Fielding Lapses in Kanpur Show Why Uttar Pradesh Cannot Rely Solely on Batting Power 



























